First human test: scientists check safety of new drug in healthy women
Knowledge-focused
Completed
This was a first-in-human study to check the basic safety of a new drug called AMN1126 and see how the body processes it. It involved 18 healthy postmenopausal women who received a single, increasing dose of the drug. The main goal was to monitor for any side effects and measure …
Phase: PHASE1 • Sponsor: Amneal Pharmaceuticals, LLC • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC